Physician profile
Walter E Kaufmann
NPI 1609930312
$30,814.50
in general payments reported to CMS, 2019-2025
4 companies · $11K in 2025
The $11K reported for 2025 was more than what 91% of Neurodevelopmental Disabilities (Psychiatry & Neurology) providers received nationally (typical 2025 total: $328).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2024: $8,449 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,200 · Travel and Lodging: $1,557 · Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,892.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,200.00 |
| Travel and Lodging | $1,556.76 |
| Food and Beverage | $865.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $12,975.86 | 2024-2025 | S-217622 |
| Gw Research Limited | $11,300.00 | 2019 | |
| Acadia Pharmaceuticals INC | $6,185.64 | 2025 | Daybue |
| Emd Serono, INC. | $353.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Kaufmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.